Overcoming Obstacles to Clinical Trials Enrollment Through a Navigator Program
NCT ID: NCT01032447
Last Updated: 2016-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
45 participants
OBSERVATIONAL
2010-01-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enhancing the Patient Journey to Clinical Trial Enrolment with Navigation to Optimize Accrual
NCT06905002
Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study
NCT03245788
Clinical Trial Navigation to Increase Participation and Diversity in Cancer Clinical Trials
NCT06484595
Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
NCT06138067
Can Electronic Information Kiosks Enhance Patient Accrual for Cancer Clinical Trials? A Pilot and Feasibility Study
NCT03747276
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Navigator Support
Standard of Care
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis of any gynecologic or breast cancer and be pursuing treatment here at Stanford within the last 2 years
* must read and speak Chinese
* willing and able to participant in group discussions
Cancer patients to receive Navigator Support must meet the following criterion:
* Newly diagnosed with gynecologic or breast cancer -pursuing treatment at Stanford Cancer Center
* must read and speak Chinese
* willing and able to have an individual relationship with a Navigator
Health Professional must meet the following criterion:
-must currently work in the Stanford gynecologic Oncology Clinic
Navigators must meet the following criterion:
* Chinese and English speaking
* willing and able to participate in training and to serve as a Navigator
* preferably a Cancer survivor
Exclusion Criteria
No Exclusionary criterion for Health Professionals or Navigators.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nelson N Teng
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University School of Medicine
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GYN0001
Identifier Type: OTHER
Identifier Source: secondary_id
SU-10262009-4240
Identifier Type: OTHER
Identifier Source: secondary_id
GYN0001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.